Poor correlation between stated and found concentrations of diphenylmethane-4,4'-diisocyanate (4,4'-MDI) in petrolatum patch-test preparations

Contact Dermatitis
Malin FrickMagnus Bruze

Abstract

Diphenylmethane diisocyanate (MDI) is widely used in its polymeric form in the manufacturing of polyurethane products. Previous reports on MDI-related contact allergy have shown a pattern, where patients seem to react to their own MDI-based work material but not to commercial patch-test preparations, which contain 4,4'-MDI. Therefore, we performed chemical analyses of 14 commercial test preparations of 4,4'-MDI obtained from 8 European and 4 American dermatology departments as well as 2 preparations from 2 major European suppliers of patch-test allergens. A new method for monitoring 4,4'-MDI in petrolatum preparations was developed and the determination of 4,4'-MDI as the MDI-dibutylamine derivative using liquid chromatography-mass spectrometry was performed. None of the preparations obtained from the dermatology departments contained more than 12% of the concentration stated on the label. In most cases, 4,4'-MDI content was only a few percentages or less of the concentration stated. 7 of the 14 preparations were analysed before the expiry date. Yet, only 1 of them, a preparation directly obtained from the supplier, came close to the concentration stated on the label. Thus, using these preparations, patients will be tested with...Continue Reading

Citations

Jul 22, 2009·Der Hautarzt; Zeitschrift für Dermatologie, Venerologie, und verwandte Gebiete·J GeierH Lessmann
Apr 14, 2007·Environmental Health Perspectives·Dhimiter BelloCarrie A Redlich
Sep 14, 2013·Dermatitis : Contact, Atopic, Occupational, Drug·Nicole Marie JoyAmber Reck Atwater
Jun 28, 2006·Dermatitis : Contact, Atopic, Occupational, Drug·Robert L RietschelDonald V Belsito
Jun 2, 2012·Dermatitis : Contact, Atopic, Occupational, Drug·Kurt S Wenk, Alison Ehrlich
Jul 8, 2009·Dermatologic Clinics·Lauren Y CaoJames S Taylor
Dec 21, 2004·Contact Dermatitis·Birgitta GruvbergerMagnus Bruze
Aug 8, 2007·Contact Dermatitis·Malin Frick-EngfeldtMagnus Bruze
Mar 21, 2008·Contact Dermatitis·Kristina RybergMagnus Bruze
Jul 23, 2013·Contact Dermatitis·Malin Engfeldt, Ann Pontén
Mar 21, 2012·Contact Dermatitis·Kristiina Aalto-KorteRiitta Jolanki
Jul 3, 2013·Contact Dermatitis·Kristian Fredløv MoseLars Porskjær Christensen
Nov 19, 2011·Contact Dermatitis·Haneen HamadaErik Zimerson
Nov 3, 2010·The British Journal of Dermatology·A T J GoonM Isaksson
Jul 19, 2012·The British Journal of Dermatology·M MowitzM Bruze
Nov 13, 2010·Contact Dermatitis·Kristiina Aalto-KorteRiitta Jolanki
Nov 15, 2011·Contact Dermatitis·Malin EngfeldtMagnus Bruze
Sep 28, 2012·The British Journal of Dermatology·D A Buckley
Mar 13, 2014·International Journal of Occupational Medicine and Environmental Health·Marta Kieć-ŚwierczyńskaBeata Kręcisz
Mar 11, 2015·Dermatitis : Contact, Atopic, Occupational, Drug·Dianne BurrowsSandy Skotnicki
Jul 20, 2016·Dermatitis : Contact, Atopic, Occupational, Drug·Paul C JouErin M Warshaw
Apr 21, 2010·Expert Review of Clinical Immunology·Iris S Ale, Howard A Maibacht
May 10, 2021·Contact Dermatitis·Mette L HansenHenrik A Kolstad
May 22, 2021·Contact Dermatitis·Karolina WojewodaLina Hagvall
Jul 7, 2021·Immunology and Allergy Clinics of North America·Itai ChipindaPaul D Siegel

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bipolar Disorder

Bipolar disorder is characterized by manic and/or depressive episodes and associated with uncommon shifts in mood, activity levels, and energy. Discover the latest research this illness here.

© 2021 Meta ULC. All rights reserved